| No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * [Number of genes] |
KEGG DRUG * |
DrugBank |
Disease ID * [Number of diseases] |
| 1 | Acute myeloid leukemia 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] KIT |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| 2 | Adipocytokine signaling pathway 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] PPARA |
D00565 |
Fenofibrate |
[5] 8, 79, 93, 94, 265 |
| 3 | Adrenergic signaling in cardiomyocytes 12 genes, 4 drugs (DrugBank), 4 diseases shown |
[3] ADRA1A, ADRA1B, ADRA1D |
D00454 |
Olanzapine |
[2] 2, 8 |
| D06623 |
| [4] ATP1A1, ATP1A2, ATP1A3, ATP1A4 |
D00298 |
Digoxin |
[2] 8, 46 |
| [4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| [1] SCN5A |
D00642 |
Quinidine |
[3] 2, 8, 13 |
| D00643 |
| D02272 |
| D08458 |
| 4 | AGE-RAGE signaling pathway in diabetic complications 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 5 | Alanine, aspartate and glutamate metabolism 4 genes, 1 drug (DrugBank), 14 diseases shown |
[4] ABAT, ALDH5A1, GAD1, GAD2 |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| 6 | Alcoholism 8 genes, 12 drugs (DrugBank), 18 diseases shown |
[1] DRD2 |
D00136 |
Haloperidol |
[1] 8 |
| D01898 |
| D00454 |
Olanzapine |
[2] 2, 8 |
| D06623 |
| D09953 |
Pridopidine |
[2] 6, 8 |
| D00426 |
Risperidone |
[5] 8, 156, 179, 187, 206 |
| [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00777 |
Amantadine |
[4] 6, 8, 13, 127 |
| D07441 |
| D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| D09917 |
Latrepirdine |
[1] 8 |
| D04905 |
Memantine |
[7] 2, 6, 8, 13, 49, 127, 205 |
| D08174 |
| D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
| [1] SLC18A2 |
D08575 |
Tetrabenazine |
[1] 8 |
| D10675 |
Valbenazine |
[1] 8 |
| [1] SLC6A3 |
D00817 |
Bupropion |
[2] 8, 96 |
| D07591 |
| D07938 |
| 7 | Aldosterone synthesis and secretion 7 genes, 2 drugs (DrugBank), 15 diseases shown |
[4] ATP1A1, ATP1A2, ATP1A3, ATP1A4 |
D00298 |
Digoxin |
[2] 8, 46 |
| [3] CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| 8 | Aldosterone-regulated sodium reabsorption 4 genes, 1 drug (DrugBank), 2 diseases shown |
[4] ATP1A1, ATP1A2, ATP1A3, ATP1A4 |
D00298 |
Digoxin |
[2] 8, 46 |
| 9 | Alzheimer disease 5 genes, 5 drugs (DrugBank), 16 diseases shown |
[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00777 |
Amantadine |
[4] 6, 8, 13, 127 |
| D07441 |
| D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| D09917 |
Latrepirdine |
[1] 8 |
| D04905 |
Memantine |
[7] 2, 6, 8, 13, 49, 127, 205 |
| D08174 |
| D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
| 10 | Amphetamine addiction 11 genes, 8 drugs (DrugBank), 16 diseases shown |
[9] GRIA1, GRIA2, GRIA3, GRIA4, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
| [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00777 |
Amantadine |
[4] 6, 8, 13, 127 |
| D07441 |
| D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| D09917 |
Latrepirdine |
[1] 8 |
| D04905 |
Memantine |
[7] 2, 6, 8, 13, 49, 127, 205 |
| D08174 |
| [1] SLC18A2 |
D08575 |
Tetrabenazine |
[1] 8 |
| D10675 |
Valbenazine |
[1] 8 |
| [1] SLC6A3 |
D00817 |
Bupropion |
[2] 8, 96 |
| D07591 |
| D07938 |
| 11 | AMPK signaling pathway 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] ADRA1A |
D00454 |
Olanzapine |
[2] 2, 8 |
| D06623 |
| 12 | Amyotrophic lateral sclerosis (ALS) 11 genes, 6 drugs (DrugBank), 16 diseases shown |
[7] GRIA1, GRIA2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
| [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00777 |
Amantadine |
[4] 6, 8, 13, 127 |
| D07441 |
| D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| D09917 |
Latrepirdine |
[1] 8 |
| D04905 |
Memantine |
[7] 2, 6, 8, 13, 49, 127, 205 |
| D08174 |
| [4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 13 | Axon guidance 2 genes, 2 drugs (DrugBank), 6 diseases shown |
[1] ABL1 |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [1] SEMA4D |
D11469 |
Pepinemab |
[2] 8, 13 |
| 14 | beta-Alanine metabolism 3 genes, 1 drug (DrugBank), 14 diseases shown |
[3] ABAT, GAD1, GAD2 |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| 15 | Bile secretion 5 genes, 2 drugs (DrugBank), 13 diseases shown |
[4] ATP1A1, ATP1A2, ATP1A3, ATP1A4 |
D00298 |
Digoxin |
[2] 8, 46 |
| [1] NR1H4 |
D00734 |
Ursodeoxycholic acid |
[12] 6, 8, 20, 67, 84, 93, 94, 95, 96, 97, 234, 299 |
| 16 | Breast cancer 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] KIT |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| 17 | Butanoate metabolism 4 genes, 1 drug (DrugBank), 14 diseases shown |
[4] ABAT, ALDH5A1, GAD1, GAD2 |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| 18 | C-type lectin receptor signaling pathway 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 19 | Calcium signaling pathway 17 genes, 9 drugs (DrugBank), 30 diseases shown |
[8] ADRA1A, ADRA1B, ADRA1D, HRH1, HTR2A, HTR2B, HTR2C, HTR6 |
D00454 |
Olanzapine |
[2] 2, 8 |
| D06623 |
| [3] CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| [4] GRIN1, GRIN2A, GRIN2C, GRIN2D |
D00777 |
Amantadine |
[4] 6, 8, 13, 127 |
| D07441 |
| D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| D09917 |
Latrepirdine |
[1] 8 |
| D04905 |
Memantine |
[7] 2, 6, 8, 13, 49, 127, 205 |
| D08174 |
| D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
| [1] HTR2A |
D00426 |
Risperidone |
[5] 8, 156, 179, 187, 206 |
| [2] PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| 20 | cAMP signaling pathway 20 genes, 12 drugs (DrugBank), 22 diseases shown |
[4] ATP1A1, ATP1A2, ATP1A3, ATP1A4 |
D00298 |
Digoxin |
[2] 8, 46 |
| [1] DRD2 |
D00136 |
Haloperidol |
[1] 8 |
| D01898 |
| D09953 |
Pridopidine |
[2] 6, 8 |
| D00426 |
Risperidone |
[5] 8, 156, 179, 187, 206 |
| [2] DRD2, HTR6 |
D00454 |
Olanzapine |
[2] 2, 8 |
| D06623 |
| [9] GRIA1, GRIA2, GRIA3, GRIA4, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
| [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00777 |
Amantadine |
[4] 6, 8, 13, 127 |
| D07441 |
| D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| D09917 |
Latrepirdine |
[1] 8 |
| D04905 |
Memantine |
[7] 2, 6, 8, 13, 49, 127, 205 |
| D08174 |
| [4] PDE4A, PDE4B, PDE4C, PDE4D |
D01783 |
Rolipram |
[2] 8, 13 |
| [1] PPARA |
D00565 |
Fenofibrate |
[5] 8, 79, 93, 94, 265 |
| 21 | Carbohydrate digestion and absorption 4 genes, 1 drug (DrugBank), 2 diseases shown |
[4] ATP1A1, ATP1A2, ATP1A3, ATP1A4 |
D00298 |
Digoxin |
[2] 8, 46 |
| 22 | Cardiac muscle contraction 4 genes, 1 drug (DrugBank), 2 diseases shown |
[4] ATP1A1, ATP1A2, ATP1A3, ATP1A4 |
D00298 |
Digoxin |
[2] 8, 46 |
| 23 | Cell cycle 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] ABL1 |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| 24 | Cellular senescence 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 25 | Central carbon metabolism in cancer 3 genes, 1 drug (DrugBank), 5 diseases shown |
[3] KIT, PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| 26 | cGMP-PKG signaling pathway 10 genes, 3 drugs (DrugBank), 3 diseases shown |
[3] ADRA1A, ADRA1B, ADRA1D |
D00454 |
Olanzapine |
[2] 2, 8 |
| D06623 |
| [3] ADRA2A, ADRA2B, ADRA2C |
D08482 |
Rilmenidine |
[1] 8 |
| [4] ATP1A1, ATP1A2, ATP1A3, ATP1A4 |
D00298 |
Digoxin |
[2] 8, 46 |
| 27 | Chagas disease (American trypanosomiasis) 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 28 | Choline metabolism in cancer 2 genes, 1 drug (DrugBank), 5 diseases shown |
[2] PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| 29 | Cholinergic synapse 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] ACHE |
D09917 |
Latrepirdine |
[1] 8 |
| 30 | Chronic myeloid leukemia 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] ABL1 |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| 31 | Circadian entrainment 14 genes, 7 drugs (DrugBank), 26 diseases shown |
[3] CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| [9] GRIA1, GRIA2, GRIA3, GRIA4, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
| [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00777 |
Amantadine |
[4] 6, 8, 13, 127 |
| D07441 |
| D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| D09917 |
Latrepirdine |
[1] 8 |
| D04905 |
Memantine |
[7] 2, 6, 8, 13, 49, 127, 205 |
| D08174 |
| [2] MTNR1A, MTNR1B |
D02689 |
Ramelteon |
[3] 6, 8, 46 |
| 32 | Cocaine addiction 9 genes, 12 drugs (DrugBank), 18 diseases shown |
[1] DRD2 |
D00136 |
Haloperidol |
[1] 8 |
| D01898 |
| D00454 |
Olanzapine |
[2] 2, 8 |
| D06623 |
| D09953 |
Pridopidine |
[2] 6, 8 |
| D00426 |
Risperidone |
[5] 8, 156, 179, 187, 206 |
| [6] GRIA2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
| [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00777 |
Amantadine |
[4] 6, 8, 13, 127 |
| D07441 |
| D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| D09917 |
Latrepirdine |
[1] 8 |
| D04905 |
Memantine |
[7] 2, 6, 8, 13, 49, 127, 205 |
| D08174 |
| [1] SLC18A2 |
D08575 |
Tetrabenazine |
[1] 8 |
| D10675 |
Valbenazine |
[1] 8 |
| [1] SLC6A3 |
D00817 |
Bupropion |
[2] 8, 96 |
| D07591 |
| D07938 |
| 33 | Collecting duct acid secretion 2 genes, 1 drug (DrugBank), 15 diseases shown |
[2] ATP4A, ATP4B |
D00455 |
Omeprazole |
[15] 6, 8, 13, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
| D01207 |
| D05259 |
| D05261 |
| 34 | Cortisol synthesis and secretion 4 genes, 2 drugs (DrugBank), 16 diseases shown |
[3] CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| [1] CYP17A1 |
D00351 |
Ketoconazole |
[3] 8, 13, 75 |
| 35 | Cushing syndrome 4 genes, 2 drugs (DrugBank), 16 diseases shown |
[3] CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| [1] CYP17A1 |
D00351 |
Ketoconazole |
[3] 8, 13, 75 |
| 36 | Dopaminergic synapse 16 genes, 14 drugs (DrugBank), 18 diseases shown |
[1] DRD2 |
D00136 |
Haloperidol |
[1] 8 |
| D01898 |
| D09953 |
Pridopidine |
[2] 6, 8 |
| D00426 |
Risperidone |
[5] 8, 156, 179, 187, 206 |
| [3] DRD2, DRD3, DRD4 |
D00454 |
Olanzapine |
[2] 2, 8 |
| D06623 |
| [6] GRIA1, GRIA2, GRIA3, GRIA4, GRIN2A, GRIN2B |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
| [2] GRIN2A, GRIN2B |
D00777 |
Amantadine |
[4] 6, 8, 13, 127 |
| D07441 |
| D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| D09917 |
Latrepirdine |
[1] 8 |
| D04905 |
Memantine |
[7] 2, 6, 8, 13, 49, 127, 205 |
| D08174 |
| [4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| [1] SCN1A |
D00642 |
Quinidine |
[3] 2, 8, 13 |
| D00643 |
| D02272 |
| D08458 |
| [1] SLC18A2 |
D08575 |
Tetrabenazine |
[1] 8 |
| D10675 |
Valbenazine |
[1] 8 |
| [1] SLC6A3 |
D00817 |
Bupropion |
[2] 8, 96 |
| D07591 |
| D07938 |
| 37 | EGFR tyrosine kinase inhibitor resistance 2 genes, 1 drug (DrugBank), 5 diseases shown |
[2] PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| 38 | Endocrine and other factor-regulated calcium reabsorption 4 genes, 1 drug (DrugBank), 2 diseases shown |
[4] ATP1A1, ATP1A2, ATP1A3, ATP1A4 |
D00298 |
Digoxin |
[2] 8, 46 |
| 39 | Endocrine resistance 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 40 | Endocytosis 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] PDGFRA |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| 41 | Epithelial cell signaling in Helicobacter pylori infection 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 42 | Epstein-Barr virus infection 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 43 | ErbB signaling pathway 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] ABL1 |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| 44 | Fc epsilon RI signaling pathway 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 45 | Fluid shear stress and atherosclerosis 5 genes, 2 drugs (DrugBank), 10 diseases shown |
[4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| [1] NQO1 |
D00564 |
Warfarin |
[10] 6, 8, 13, 19, 46, 49, 66, 85, 88, 96 |
| D01280 |
| D08682 |
| 46 | Focal adhesion 2 genes, 1 drug (DrugBank), 5 diseases shown |
[2] PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| 47 | FoxO signaling pathway 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 48 | GABAergic synapse 19 genes, 2 drugs (DrugBank), 14 diseases shown |
[3] ABAT, GAD1, GAD2 |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00225 |
Alprazolam |
[1] 8 |
| 49 | Gap junction 6 genes, 5 drugs (DrugBank), 10 diseases shown |
[1] DRD2 |
D00136 |
Haloperidol |
[1] 8 |
| D01898 |
| D09953 |
Pridopidine |
[2] 6, 8 |
| [2] DRD2, HTR2A |
D00426 |
Risperidone |
[5] 8, 156, 179, 187, 206 |
| [4] DRD2, HTR2A, HTR2B, HTR2C |
D00454 |
Olanzapine |
[2] 2, 8 |
| D06623 |
| [2] PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| 50 | Gastric acid secretion 6 genes, 2 drugs (DrugBank), 15 diseases shown |
[4] ATP1A1, ATP1A2, ATP1A3, ATP1A4 |
D00298 |
Digoxin |
[2] 8, 46 |
| [2] ATP4A, ATP4B |
D00455 |
Omeprazole |
[15] 6, 8, 13, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
| D01207 |
| D05259 |
| D05261 |
| 51 | Glioma 2 genes, 1 drug (DrugBank), 5 diseases shown |
[2] PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| 52 | Glucagon signaling pathway 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] PPARA |
D00565 |
Fenofibrate |
[5] 8, 79, 93, 94, 265 |
| 53 | Glutamatergic synapse 14 genes, 5 drugs (DrugBank), 16 diseases shown |
[14] GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
| [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00777 |
Amantadine |
[4] 6, 8, 13, 127 |
| D07441 |
| D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| D09917 |
Latrepirdine |
[1] 8 |
| D04905 |
Memantine |
[7] 2, 6, 8, 13, 49, 127, 205 |
| D08174 |
| 54 | Glycerophospholipid metabolism 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] ACHE |
D09917 |
Latrepirdine |
[1] 8 |
| 55 | GnRH secretion 3 genes, 1 drug (DrugBank), 14 diseases shown |
[3] CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| 56 | GnRH signaling pathway 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 57 | Growth hormone synthesis, secretion and action 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 58 | Hematopoietic cell lineage 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] KIT |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| 59 | Hepatitis B 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 60 | Hepatitis C 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] PPARA |
D00565 |
Fenofibrate |
[5] 8, 79, 93, 94, 265 |
| 61 | Hepatocellular carcinoma 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] NQO1 |
D00564 |
Warfarin |
[10] 6, 8, 13, 19, 46, 49, 66, 85, 88, 96 |
| D01280 |
| D08682 |
| 62 | Human cytomegalovirus infection 5 genes, 2 drugs (DrugBank), 5 diseases shown |
[4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| [1] PDGFRA |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| 63 | Human immunodeficiency virus 1 infection 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 64 | Human papillomavirus infection 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| 65 | Huntington disease 2 genes, 5 drugs (DrugBank), 16 diseases shown |
[2] GRIN1, GRIN2B |
D00777 |
Amantadine |
[4] 6, 8, 13, 127 |
| D07441 |
| D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| D09917 |
Latrepirdine |
[1] 8 |
| D04905 |
Memantine |
[7] 2, 6, 8, 13, 49, 127, 205 |
| D08174 |
| D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
| 66 | IL-17 signaling pathway 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 67 | Inflammatory mediator regulation of TRP channels 8 genes, 3 drugs (DrugBank), 6 diseases shown |
[4] HRH1, HTR2A, HTR2B, HTR2C |
D00454 |
Olanzapine |
[2] 2, 8 |
| D06623 |
| [1] HTR2A |
D00426 |
Risperidone |
[5] 8, 156, 179, 187, 206 |
| [4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 68 | Insulin resistance 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] PPARA |
D00565 |
Fenofibrate |
[5] 8, 79, 93, 94, 265 |
| 69 | Insulin secretion 4 genes, 1 drug (DrugBank), 2 diseases shown |
[4] ATP1A1, ATP1A2, ATP1A3, ATP1A4 |
D00298 |
Digoxin |
[2] 8, 46 |
| 70 | JAK-STAT signaling pathway 2 genes, 1 drug (DrugBank), 5 diseases shown |
[2] PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| 71 | Kaposi sarcoma-associated herpesvirus infection 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 72 | Leishmaniasis 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 73 | Leukocyte transendothelial migration 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 74 | Long-term depression 3 genes, 1 drug (DrugBank), 7 diseases shown |
[3] GRIA1, GRIA2, GRIA3 |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
| 75 | Long-term potentiation 7 genes, 5 drugs (DrugBank), 16 diseases shown |
[7] GRIA1, GRIA2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
| [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00777 |
Amantadine |
[4] 6, 8, 13, 127 |
| D07441 |
| D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| D09917 |
Latrepirdine |
[1] 8 |
| D04905 |
Memantine |
[7] 2, 6, 8, 13, 49, 127, 205 |
| D08174 |
| 76 | MAPK signaling pathway 10 genes, 3 drugs (DrugBank), 17 diseases shown |
[3] CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| [3] KIT, PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 77 | Melanogenesis 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] KIT |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| 78 | Melanoma 2 genes, 1 drug (DrugBank), 5 diseases shown |
[2] PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| 79 | Metabolic pathways 13 genes, 5 drugs (DrugBank), 33 diseases shown |
[4] ABAT, ALDH5A1, GAD1, GAD2 |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| [2] ATP4A, ATP4B |
D00455 |
Omeprazole |
[15] 6, 8, 13, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
| D01207 |
| D05259 |
| D05261 |
| [1] CYP17A1 |
D00351 |
Ketoconazole |
[3] 8, 13, 75 |
| [2] NQO1, VKORC1 |
D00564 |
Warfarin |
[10] 6, 8, 13, 19, 46, 49, 66, 85, 88, 96 |
| D01280 |
| D08682 |
| [4] PDE4A, PDE4B, PDE4C, PDE4D |
D01783 |
Rolipram |
[2] 8, 13 |
| 80 | MicroRNAs in cancer 3 genes, 1 drug (DrugBank), 5 diseases shown |
[3] ABL1, PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| 81 | Mineral absorption 4 genes, 1 drug (DrugBank), 2 diseases shown |
[4] ATP1A1, ATP1A2, ATP1A3, ATP1A4 |
D00298 |
Digoxin |
[2] 8, 46 |
| 82 | Morphine addiction 20 genes, 2 drugs (DrugBank), 2 diseases shown |
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00225 |
Alprazolam |
[1] 8 |
| [4] PDE4A, PDE4B, PDE4C, PDE4D |
D01783 |
Rolipram |
[2] 8, 13 |
| 83 | Neuroactive ligand-receptor interaction 46 genes, 12 drugs (DrugBank), 18 diseases shown |
[11] ADRA1A, ADRA1B, ADRA1D, DRD2, DRD3, DRD4, HRH1, HTR2A, HTR2B, HTR2C, HTR6 |
D00454 |
Olanzapine |
[2] 2, 8 |
| D06623 |
| [3] ADRA2A, ADRA2B, ADRA2C |
D08482 |
Rilmenidine |
[1] 8 |
| [1] DRD2 |
D00136 |
Haloperidol |
[1] 8 |
| D01898 |
| D09953 |
Pridopidine |
[2] 6, 8 |
| [2] DRD2, HTR2A |
D00426 |
Risperidone |
[5] 8, 156, 179, 187, 206 |
| [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00225 |
Alprazolam |
[1] 8 |
| [14] GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
| [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00777 |
Amantadine |
[4] 6, 8, 13, 127 |
| D07441 |
| D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| D09917 |
Latrepirdine |
[1] 8 |
| D04905 |
Memantine |
[7] 2, 6, 8, 13, 49, 127, 205 |
| D08174 |
| [2] MTNR1A, MTNR1B |
D02689 |
Ramelteon |
[3] 6, 8, 46 |
| 84 | Neurotrophin signaling pathway 5 genes, 2 drugs (DrugBank), 5 diseases shown |
[1] ABL1 |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 85 | Nicotine addiction 25 genes, 6 drugs (DrugBank), 16 diseases shown |
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00225 |
Alprazolam |
[1] 8 |
| [9] GRIA1, GRIA2, GRIA3, GRIA4, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
| [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00777 |
Amantadine |
[4] 6, 8, 13, 127 |
| D07441 |
| D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| D09917 |
Latrepirdine |
[1] 8 |
| D04905 |
Memantine |
[7] 2, 6, 8, 13, 49, 127, 205 |
| D08174 |
| 86 | NOD-like receptor signaling pathway 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 87 | Non-alcoholic fatty liver disease (NAFLD) 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] PPARA |
D00565 |
Fenofibrate |
[5] 8, 79, 93, 94, 265 |
| 88 | Oocyte meiosis 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 89 | Osteoclast differentiation 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 90 | Ovarian steroidogenesis 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] CYP17A1 |
D00351 |
Ketoconazole |
[3] 8, 13, 75 |
| 91 | Oxidative phosphorylation 2 genes, 1 drug (DrugBank), 15 diseases shown |
[2] ATP4A, ATP4B |
D00455 |
Omeprazole |
[15] 6, 8, 13, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
| D01207 |
| D05259 |
| D05261 |
| 92 | Pancreatic secretion 4 genes, 1 drug (DrugBank), 2 diseases shown |
[4] ATP1A1, ATP1A2, ATP1A3, ATP1A4 |
D00298 |
Digoxin |
[2] 8, 46 |
| 93 | Parathyroid hormone synthesis, secretion and action 4 genes, 1 drug (DrugBank), 2 diseases shown |
[4] PDE4A, PDE4B, PDE4C, PDE4D |
D01783 |
Rolipram |
[2] 8, 13 |
| 94 | Parkinson disease 3 genes, 7 drugs (DrugBank), 8 diseases shown |
[1] DRD2 |
D00136 |
Haloperidol |
[1] 8 |
| D01898 |
| D00454 |
Olanzapine |
[2] 2, 8 |
| D06623 |
| D09953 |
Pridopidine |
[2] 6, 8 |
| D00426 |
Risperidone |
[5] 8, 156, 179, 187, 206 |
| [1] SLC18A2 |
D08575 |
Tetrabenazine |
[1] 8 |
| D10675 |
Valbenazine |
[1] 8 |
| [1] SLC6A3 |
D00817 |
Bupropion |
[2] 8, 96 |
| D07591 |
| D07938 |
| 95 | Pathogenic Escherichia coli infection 5 genes, 2 drugs (DrugBank), 5 diseases shown |
[1] ABL1 |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 96 | Pathways in cancer 5 genes, 2 drugs (DrugBank), 13 diseases shown |
[4] ABL1, KIT, PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [1] NQO1 |
D00564 |
Warfarin |
[10] 6, 8, 13, 19, 46, 49, 66, 85, 88, 96 |
| D01280 |
| D08682 |
| 97 | PD-L1 expression and PD-1 checkpoint pathway in cancer 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 98 | Pertussis 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 99 | Phospholipase D signaling pathway 3 genes, 1 drug (DrugBank), 5 diseases shown |
[3] KIT, PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| 100 | PI3K-Akt signaling pathway 3 genes, 1 drug (DrugBank), 5 diseases shown |
[3] KIT, PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| 101 | Platelet activation 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 102 | PPAR signaling pathway 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] PPARA |
D00565 |
Fenofibrate |
[5] 8, 79, 93, 94, 265 |
| 103 | Progesterone-mediated oocyte maturation 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 104 | Prolactin signaling pathway 5 genes, 2 drugs (DrugBank), 3 diseases shown |
[1] CYP17A1 |
D00351 |
Ketoconazole |
[3] 8, 13, 75 |
| [4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 105 | Propanoate metabolism 1 gene, 1 drug (DrugBank), 14 diseases shown |
[1] ABAT |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| 106 | Prostate cancer 2 genes, 1 drug (DrugBank), 5 diseases shown |
[2] PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| 107 | Protein digestion and absorption 4 genes, 1 drug (DrugBank), 2 diseases shown |
[4] ATP1A1, ATP1A2, ATP1A3, ATP1A4 |
D00298 |
Digoxin |
[2] 8, 46 |
| 108 | Proteoglycans in cancer 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 109 | Proximal tubule bicarbonate reclamation 4 genes, 1 drug (DrugBank), 2 diseases shown |
[4] ATP1A1, ATP1A2, ATP1A3, ATP1A4 |
D00298 |
Digoxin |
[2] 8, 46 |
| 110 | Purine metabolism 4 genes, 1 drug (DrugBank), 2 diseases shown |
[4] PDE4A, PDE4B, PDE4C, PDE4D |
D01783 |
Rolipram |
[2] 8, 13 |
| 111 | Rap1 signaling pathway 11 genes, 11 drugs (DrugBank), 21 diseases shown |
[1] DRD2 |
D00136 |
Haloperidol |
[1] 8 |
| D01898 |
| D00454 |
Olanzapine |
[2] 2, 8 |
| D06623 |
| D09953 |
Pridopidine |
[2] 6, 8 |
| D00426 |
Risperidone |
[5] 8, 156, 179, 187, 206 |
| [3] GRIN1, GRIN2A, GRIN2B |
D00777 |
Amantadine |
[4] 6, 8, 13, 127 |
| D07441 |
| D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| D09917 |
Latrepirdine |
[1] 8 |
| D04905 |
Memantine |
[7] 2, 6, 8, 13, 49, 127, 205 |
| D08174 |
| D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
| [3] KIT, PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 112 | Ras signaling pathway 7 genes, 6 drugs (DrugBank), 19 diseases shown |
[4] ABL1, KIT, PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [3] GRIN1, GRIN2A, GRIN2B |
D00777 |
Amantadine |
[4] 6, 8, 13, 127 |
| D07441 |
| D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| D09917 |
Latrepirdine |
[1] 8 |
| D04905 |
Memantine |
[7] 2, 6, 8, 13, 49, 127, 205 |
| D08174 |
| D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
| 113 | Regulation of actin cytoskeleton 2 genes, 1 drug (DrugBank), 5 diseases shown |
[2] PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| 114 | Relaxin signaling pathway 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 115 | Retrograde endocannabinoid signaling 24 genes, 3 drugs (DrugBank), 7 diseases shown |
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00225 |
Alprazolam |
[1] 8 |
| [4] GRIA1, GRIA2, GRIA3, GRIA4 |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
| [4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 116 | RIG-I-like receptor signaling pathway 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 117 | Salivary secretion 7 genes, 2 drugs (DrugBank), 3 diseases shown |
[3] ADRA1A, ADRA1B, ADRA1D |
D00454 |
Olanzapine |
[2] 2, 8 |
| D06623 |
| [4] ATP1A1, ATP1A2, ATP1A3, ATP1A4 |
D00298 |
Digoxin |
[2] 8, 46 |
| 118 | Salmonella infection 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 119 | Serotonergic synapse 9 genes, 7 drugs (DrugBank), 9 diseases shown |
[3] GABRB1, GABRB2, GABRB3 |
D00225 |
Alprazolam |
[1] 8 |
| [1] HTR2A |
D00426 |
Risperidone |
[5] 8, 156, 179, 187, 206 |
| [4] HTR2A, HTR2B, HTR2C, HTR6 |
D00454 |
Olanzapine |
[2] 2, 8 |
| D06623 |
| [1] SLC18A2 |
D08575 |
Tetrabenazine |
[1] 8 |
| D10675 |
Valbenazine |
[1] 8 |
| [1] SLC6A4 |
D00822 |
Citalopram |
[3] 8, 46, 127 |
| D07704 |
| D00825 |
Sertraline |
[3] 6, 8, 206 |
| D02360 |
| 120 | Shigellosis 5 genes, 2 drugs (DrugBank), 5 diseases shown |
[1] ABL1 |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 121 | Signaling pathways regulating pluripotency of stem cells 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 122 | Sphingolipid signaling pathway 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 123 | Steroid hormone biosynthesis 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] CYP17A1 |
D00351 |
Ketoconazole |
[3] 8, 13, 75 |
| 124 | Synaptic vesicle cycle 4 genes, 6 drugs (DrugBank), 7 diseases shown |
[1] SLC18A2 |
D08575 |
Tetrabenazine |
[1] 8 |
| D10675 |
Valbenazine |
[1] 8 |
| [1] SLC6A2 |
D02574 |
Atomoxetine |
[3] 6, 8, 13 |
| D07473 |
| [2] SLC6A2, SLC6A3 |
D00817 |
Bupropion |
[2] 8, 96 |
| D07591 |
| D07938 |
| [1] SLC6A4 |
D00822 |
Citalopram |
[3] 8, 46, 127 |
| D07704 |
| D00825 |
Sertraline |
[3] 6, 8, 206 |
| D02360 |
| 125 | Systemic lupus erythematosus 2 genes, 5 drugs (DrugBank), 16 diseases shown |
[2] GRIN2A, GRIN2B |
D00777 |
Amantadine |
[4] 6, 8, 13, 127 |
| D07441 |
| D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| D09917 |
Latrepirdine |
[1] 8 |
| D04905 |
Memantine |
[7] 2, 6, 8, 13, 49, 127, 205 |
| D08174 |
| D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
| 126 | T cell receptor signaling pathway 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 127 | Taste transduction 9 genes, 2 drugs (DrugBank), 3 diseases shown |
[6] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6 |
D00225 |
Alprazolam |
[1] 8 |
| [3] SCN2A, SCN3A, SCN9A |
D00642 |
Quinidine |
[3] 2, 8, 13 |
| D00643 |
| D02272 |
| D08458 |
| 128 | Taurine and hypotaurine metabolism 2 genes, 1 drug (DrugBank), 14 diseases shown |
[2] GAD1, GAD2 |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| 129 | Th1 and Th2 cell differentiation 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 130 | Th17 cell differentiation 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 131 | Thermogenesis 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 132 | Thyroid hormone signaling pathway 4 genes, 1 drug (DrugBank), 2 diseases shown |
[4] ATP1A1, ATP1A2, ATP1A3, ATP1A4 |
D00298 |
Digoxin |
[2] 8, 46 |
| 133 | Thyroid hormone synthesis 4 genes, 1 drug (DrugBank), 2 diseases shown |
[4] ATP1A1, ATP1A2, ATP1A3, ATP1A4 |
D00298 |
Digoxin |
[2] 8, 46 |
| 134 | TNF signaling pathway 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 135 | Toll-like receptor signaling pathway 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 136 | Toxoplasmosis 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 137 | Transcriptional misregulation in cancer 1 gene, 1 drug (DrugBank), 7 diseases shown |
[1] GRIA3 |
D00775 |
Riluzole |
[7] 2, 3, 5, 8, 13, 17, 206 |
| 138 | Tuberculosis 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 139 | Type I diabetes mellitus 2 genes, 1 drug (DrugBank), 14 diseases shown |
[2] GAD1, GAD2 |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| 140 | Type II diabetes mellitus 1 gene, 1 drug (DrugBank), 14 diseases shown |
[1] CACNA1G |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| 141 | Ubiquinone and other terpenoid-quinone biosynthesis 2 genes, 1 drug (DrugBank), 10 diseases shown |
[2] NQO1, VKORC1 |
D00564 |
Warfarin |
[10] 6, 8, 13, 19, 46, 49, 66, 85, 88, 96 |
| D01280 |
| D08682 |
| 142 | Valine, leucine and isoleucine degradation 1 gene, 1 drug (DrugBank), 14 diseases shown |
[1] ABAT |
D00399 |
Valproic Acid |
[14] 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
| 143 | Vascular smooth muscle contraction 3 genes, 1 drug (DrugBank), 2 diseases shown |
[3] ADRA1A, ADRA1B, ADRA1D |
D00454 |
Olanzapine |
[2] 2, 8 |
| D06623 |
| 144 | VEGF signaling pathway 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |
| 145 | Viral myocarditis 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] ABL1 |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| 146 | Yersinia infection 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] MAPK11, MAPK12, MAPK13, MAPK14 |
D10959 |
Neflamapimod |
[1] 8 |